EGFR and neoplasm: Recent studies have suggested that NSCLCs with uncommon EGFR mutations, including EGFR Ex20ins mutations, tend to be positive for CD8+ tumor infiltrating lymphocytes in approximately 50% to 60% of cases [8,12].